Gemfibrosil, a drug used to treat abnormal blood lipid levels, is sold under the brand name Lopid. This is less than statins. Recommended for use with dietary changes and exercise. It is not clear whether this will change the risk of heart disease. It is taken by mouth
A Anant Labs fabrica e fornece impurezas de Gemfibrozil de alta qualidade para o mercado global. Nossas impurezas EP de Gemfibrozil são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
gemfibrozil25812-30-05-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic acidLopidJezilLipurCI-719GemfibroziloGemlipidGemfibrozilumGen-FibroPentanoic acid, 5-(2,5-dimethylphenoxy)-2,2-dimethyl-2,2-Dimethyl-5-(2,5-xylyloxy)valeric acidDTXSID00206522,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeureCI 7192,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeureNSC-757024Valeric acid, 2,2-dimethyl-5-(2,5-xylyloxy)-GemfibrosilQ8X02027X3DTXCID20652CHEBI:5296Lopid RApoGemfibrozilGenGemfibrozilGenlipNuGemfibrozilApo GemfibrozilGen GemfibrozilNu GemfibrozilNovo GemfibrozilPMS GemfibrozilGemfibrozil, SBPAGemfibrozil, GenRXBayvit, GemfibroziloGemfibrozil, HealthsenseCI719EmfibRefChem:57800C10AB04247-280-2657-339-8DecrelipBolutolApo-GemfibrozilMFCD00079335Gemfibrozil (Lopid)Gemfibrozil (Standard)CholespidGemfibrilGemfibromaxFibratolFibrocitLipazilLitarekTrialminAusgemPilderCHEMBL4572,2-Dimethyl-5-(2,5-dimethylphenoxy)pentanoic acidMLS000028421RenabrazinClearolElmoganFetinorGemnpidInnogenIpolipidLanateromLifibronLipigemLipizylLipozidMicolipNormolipProgemzalReducelRegulipSinelipSynbrozilTaborcilTentrocBrozilLipiraGozidHidilGemdWL-GemfibrozilGevilon UnoLow-Lip5-(2,5-dimethylphenoxy)-2,2-dimethyl-pentanoic acid5-[(2,5-dimethylphenyl)oxy]-2,2-dimethylpentanoic acidGem-SNCGC00016794-09SMR000058393CAS-25812-30-0Nu-GemfibrozilNovo-GemfibrozilGemfibrozilum [INN-Latin]Gemfibrozilo [INN-Spanish]OrganolipidInnogemGemcorCCRIS 318Lopid (TN)TEVA-ASR-01000000056EINECS 247-280-2BRN 1881200Gemfibrozil (JAN/USP/INN)Hipolixan;Gemfibrozil CRSLipozid;Gemcor;UNII-Q8X02027X3HSDB 7735Emfib;Lipur;Lopid;4TXGemfibrozil [USAN:USP:INN:BAN]Prestwick_637Spectrum_000825CPD000058393GEMFIBROZIL [MI]114413-98-8Opera_ID_1658Prestwick0_000214Prestwick1_000214Prestwick2_000214Prestwick3_000214Spectrum2_001097Spectrum3_000440Spectrum4_000562Spectrum5_000750Spectrum5_001991GEMFIBROZIL [INN]GEMFIBROZIL [JAN]GEMFIBROZIL [HSDB]GEMFIBROZIL [IARC]GEMFIBROZIL [USAN]GEMFIBROZIL [VANDF]SCHEMBL4813GEMFIBROZIL [MART.]BSPBio_000227BSPBio_002060GEMFIBROZIL [USP-RS]GEMFIBROZIL [WHO-DD]KBioGR_000964KBioSS_0013052,2-Dimethyl-5-(2,5-dimethylphenoxy)valeric AcidMLS001055364MLS006011850DivK1c_000138SPECTRUM1500313SPBio_001174SPBio_002148BPBio1_000251CI-7GTPL3439orb1308681orb3025505SCHEMBL9481043Gemfibrozil, analytical standardSCHEMBL29398115HMS500G20HY-B0258RKBio1_000138KBio2_001305KBio2_003873KBio2_006441KBio3_001280GEMFIBROZIL [ORANGE BOOK]NINDS_000138GEMFIBROZIL [EP MONOGRAPH]GLXC-07494HMS1568L09HMS1920B07HMS2090K14HMS2091H11HMS2095L09HMS2230H24HMS3259M12HMS3655C06HMS3712L09HMS5079L18Pharmakon1600-10500313GEMFIBROZIL [USP MONOGRAPH]HY-B0258MSK10081Tox21_110613Tox21_201997Tox21_302784BBL010807BDBM50110590CCG-40111DL-414EBC-06088NSC757024s1729SBB012457STK618740AKOS001606691Gemfibrozil for system suitability CRSTox21_110613_1AB03034AC-4225DB01241FD23652KS-5192NC00565NSC 757024IDI1_000138NCGC00016794-01NCGC00016794-02NCGC00016794-03NCGC00016794-04NCGC00016794-05NCGC00016794-06NCGC00016794-07NCGC00016794-08NCGC00016794-10NCGC00016794-11NCGC00016794-13NCGC00016794-14NCGC00016794-20NCGC00022722-03NCGC00022722-04NCGC00022722-05NCGC00022722-06NCGC00022722-07NCGC00256601-01NCGC00259546-01ST072198SY052512Gemfibrozil 100 microg/mL in AcetonitrileSBI-0051391.P003AB00052003CS-0694895G0368G1749NS00010281SW196802-3EN300-97098C07020D00334D83091AB00052003-15AB00052003-16AB00052003_17AB00052003_18F054267Q384295SR-01000000056-3SR-01000000056-4SR-01000000056-6SR-01000000056-72,2-Dimethyl-5-(2,5-dimethylphenoxy)-pentanoic acid2,2-DIMETHYL-5-(2,5-XYLYLOXY) VALERIC ACIDBRD-K11129031-001-05-1BRD-K11129031-001-26-7BRD-K11129031-001-27-5Z1259021151Gemfibrozil, British Pharmacopoeia (BP) Reference StandardGemfibrozil, European Pharmacopoeia (EP) Reference StandardGemfibrozil, United States Pharmacopeia (USP) Reference StandardGemfibrozil, Pharmaceutical Secondary Standard; Certified Reference MaterialGemfibrozil for system suitability, European Pharmacopoeia (EP) Reference Standard2,2-Dimethyl-5-(2,5-dimethylphenoxy)pentanoic acid, 2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid, 5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic aci
